Physician profile
Hoon Choi
NPI 1639499882
$102,555.12
in general payments reported to CMS, 2019-2025
18 companies · $4,294 in 2025
The $4,294 reported for 2025 was more than what 79% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $36K · 2021: $13K · 2022: $8,024 · 2023: $1,177 · 2024: $2,379 · 2025: $4,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,699 · Food and Beverage: $3,386 · Royalty Or License: $422 · Education: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,699.25 |
| Food and Beverage | $3,386.48 |
| Royalty Or License | $422.39 |
| Education | $341.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $92,567.95 | 2019-2025 | Captivate, Excelsius Gps, Quartex |
| Medtronic, INC. | $2,546.32 | 2021-2025 | Stealthstation S8 Platform, Linq II, Catalyft Pl Expandable Interbody System |
| Nuvasive, INC. | $2,220.05 | 2021-2022 | |
| Stryker Corporation | $1,968.28 | 2021-2024 | Everest Spinal System, Yukon Oct Spinal System, Core |
| Cerapedics INC. | $1,257.21 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Orthofix Medical, INC. | $720.19 | 2022-2025 | Spinal-Stim, Trinity Elite, Spinal-Stim |
| Depuy Synthes Sales INC. | $380.08 | 2024-2025 | Na |
| Si-Bone, INC. | $206.74 | 2023 | |
| Medtronic USA, INC. | $154.32 | 2020 | |
| Monteris Medical Corporation | $138.69 | 2023-2025 | Neuroblate |
| Djo, LLC | $117.66 | 2019 | |
| Ethicon US, LLC | $88.90 | 2023 | Stratafix |
| Carbofix Spine INC | $78.26 | 2023-2024 | |
| Arthrex, INC. | $40.62 | 2024 | Arthrex |
| Janssen Biotech, INC. | $25.05 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $15.81 | 2025 | Nexus-10 Mkii |
| Zimvie INC. | $14.98 | 2023 | |
| Neurelis, INC. | $14.01 | 2025 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hoon Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.